NYSEARCA:PJP

Invesco Pharmaceuticals ETF (PJP) Price, Holdings, & News

Invesco Pharmaceuticals ETF logo
$129.86 -1.18 (-0.90%)
Closing price 04:10 PM Eastern
Extended Trading
$129.78 -0.08 (-0.06%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Invesco Pharmaceuticals ETF (NYSEARCA:PJP)

Advanced

Key Stats

Today's Range
$129.53
▼
$132.49
50-Day Range
$120.71
▼
$131.59
52-Week Range
$99.05
▼
$132.59
Volume
45,085 shs
Average Volume
36,248 shs
Market Capitalization
$601.25 million
Assets Under Management
$609.17 million
Dividend Yield
0.87%
Net Expense Ratio
0.57%
Aggregate Rating
Moderate Buy

ETF Overview

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The Fund normally invests at least 90% of its total assets in common stocks that consists of the Index. The Fund's investment advisor is Invesco PowerShares Capital Management LLC.

Invesco Pharmaceuticals ETF Expenses

TypePJPHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.50%0.55%0.57%0.50%0.53%
Other Expenses0.07%0.52%0.53%0.60%0.54%
Total Expense0.57%0.76%0.75%0.75%0.73%
Fee Waiver0.00%-0.85%-0.67%-0.76%-0.67%
Net Expense0.57%0.58%0.63%0.57%0.60%
Receive PJP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Invesco Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PJP ETF News Headlines

Why I'm selling my Snapback Indicator for just $7
For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indicator for a single $7 payment. Others previously paid $500. The indicator flashes a Crash Alert as a cue to exit or go short, and a Bull Run Alert as a cue to buy or go long. No strings attached, and Wood says there is an unusual reason behind the steep discount.tc pixel
See More Headlines

PJP ETF - Frequently Asked Questions

Invesco Pharmaceuticals ETF's stock was trading at $104.54 on January 1st, 2026. Since then, PJP shares have increased by 24.2% and is now trading at $129.86.

Top institutional investors of Invesco Pharmaceuticals ETF include HighTower Advisors LLC (5.65%), Peak Asset Management LLC (2.90%), Trek Financial LLC (1.04%) and Cetera Investment Advisers (0.54%).

Shares of PJP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Fund Details

Issuer
Invesco
Fund Name
Invesco Pharmaceuticals ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:PJP
Inception Date
6/23/2005
Fund Manager
Peter Hubbard, Michael Jeanette, Pratik Doshi, Tony Seisser

Fund Focus

Asset Class
Equity
Benchmark
Dynamic Pharmaceutical Intellidex Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Constituents
29

Fund Statistics

Assets Under Management
$609.17 million
Average Daily Volume
$37.04 thousand
Discount/Premium
0.07%

Administrator, Advisor and Custodian

Administrator
The Bank of New York Mellon Corporation
Advisor
Invesco Capital Management, LLC
Custodian
The Bank of New York Mellon Corporation
Distributor
Invesco Distributors, Inc.
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Citadel

Options

Optionable
Optionable
Options Volume
1
Put Options
0
Call Options
1
Short Interest
27,947 shs

Miscellaneous

Beta
0.43
Creation Unit
10,000
Creation Fee
$500.00
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Top 10 PJP Holdings

PJP Sector Exposure

PJP Industry Exposure


This page (NYSEARCA:PJP) was last updated on 11/16/2026 by MarketBeat.com Staff.
From Our Partners